There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

It is hoped the new norovirus jab could help lift the burden on the NHS over the busy winter months - here we explain who is ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

The Ministry of Health has approved Moderna's updated COVID vaccines, which target the new JN1 variant of the virus.

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

(see more details here). Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company that is best known for its coronavirus ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Mid- to late October is the best time to get flu and COVID vaccines, so they will be effective during November and December holiday gatherings.

Britain could become the first country to offer norovirus jab after early trial results found it creates a “strong immune ...

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...